Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Paulson & Co. Inc. · Q2 2026 13F · SEC CIK 1035674

John Paulson portfolio

Investment managerPaulson & Co. 13F holdings. Filed 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$2.6B
Reported positions
8
Top holdings a year, 3 yrs
+38.2%
Average holding period
6.3 yrs

John Paulson is the founder of Paulson & Co., which reported 8 positions worth $2.6B in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Madrigal Pharmaceuticals Inc (MDGL, 27.9%), Perpetua Resources Corporation (canada) (PPTA, 26.1%), Acadian Asset Management Inc (AAMI, 16.2%). A portfolio copying its top holdings returned 38.2% a year over the last 3 years, against 20.4% for the S&P 500.

John Paulson holdings all 8 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

John Paulson 13F holdings
Stock% of 13F valueShare changeReported value
MDGLMadrigal Pharmaceuticals Inc27.9%-3.7%$719.5M
PPTAPerpetua Resources Corporation (canada)26.1%+0.0%$671.5M
AAMIAcadian Asset Management Inc16.2%-24.5%$417.9M
BHCBausch Health Cos Inc14.0%+0.0%$361.2M
THMInternational Tower Hill Min8.1%+4.9%$207.9M
NGNovagold Resources Inc6.3%+0.0%$162.6M
THRYThryv Hldgs Inc1.3%+0.0%$33.3M
GOOGLAlphabet Inc0.1%—$1.8M

What John Paulson bought and sold in Q2 2026, against Q1 2026.

New positions

Added to

No position grew by more than 5%.

Share counts compared with the Q1 2026 13F; a split also changes share counts.

How the holdings did against the S&P 500.

1 year
+39.0% /yr
S&P 500 +20.1%
3 years
+38.2% /yr
S&P 500 +20.4%
5 years
+14.6% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$2.6B8
Q1 2026$3.1B9
Q4 2025$3.3B9
Q3 2025$3.0B10
Q2 2025$2.0B15
Q1 2025$1.7B14
Q4 2024$1.7B13
Q3 2024$1.4B15
Q2 2024$1.4B16
Q1 2024$1.4B18
Q4 2023$1.1B17
Q3 2023$1.1B18

Questions about John Paulson's portfolio

Who is John Paulson?

John Paulson is the founder of Paulson & Co., an investment manager that files its US stock holdings with the SEC on Form 13F under the name Paulson & Co. Inc..

What stocks does John Paulson own?

Paulson & Co. Inc.'s latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 8 positions worth $2.6B. The largest are Madrigal Pharmaceuticals Inc (MDGL) at 27.9%, Perpetua Resources Corporation (canada) (PPTA) at 26.1%, Acadian Asset Management Inc (AAMI) at 16.2%, Bausch Health Cos Inc (BHC) at 14.0% and International Tower Hill Min (THM) at 8.1%.

What did John Paulson buy last quarter?

In Q2 2026, Paulson & Co. Inc. added a new position in Alphabet Inc (GOOGL), compared with its Q1 2026 filing.

What did John Paulson sell last quarter?

In Q2 2026, Paulson & Co. Inc. sold all of Agnico Eagle Mines Ltd (AEM), sold all of Amicus Therapeutic (FOLD) and Acadian Asset Management Inc (AAMI) (-24.5% shares), compared with its Q1 2026 filing.

How has John Paulson's portfolio performed?

A portfolio copying Paulson & Co. Inc.'s 20 largest 13F holdings each quarter, from the day each filing was public, returned +38.2% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +39.0% against +20.1%. Over 5 years: +14.6% a year against +11.6%.

When is Paulson & Co. Inc.'s next 13F filing due?

13F filings are due 45 days after each quarter ends. Paulson & Co. Inc.'s filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.